• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dare Bioscience Inc (NQ: DARE )

    3.600 -0.040 (-1.10%)
    Streaming Delayed Price Updated: 3:54 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 14,720
    Open 3.640
    Bid (Size) 3.570 (7)
    Ask (Size) 3.610 (3)
    Prev. Close 3.640
    Today's Range 3.590 - 3.640
    52wk Range 0.2700 - 4.080
    Shares Outstanding 70,521,979
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    +994.56%
    +994.56%
    1 Month
    +712.64%
    +712.64%
    3 Month
    +1158.74%
    +1158.74%
    6 Month
    +1038.88%
    +1038.88%
    1 Year
    +376.82%
    +376.82%

    More News

    Read More
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Recap: Dare Bioscience Q4 Earnings
    Via Benzinga
    Dare Bioscience Earnings Preview
    Via Benzinga
    Earnings Outlook For Dare Bioscience
    Via Benzinga
    Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
    Via Benzinga
    DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Earnings Outlook For Dare Bioscience
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Earnings Scheduled For March 28, 2024
    Via Benzinga
    First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.